Physician profile
Leon F Smith
NPI 1841372653
$1,022.86
in general payments reported to CMS, 2019-2025
13 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $137 · 2021: $225 · 2022: $138 · 2023: $109 · 2024: $124 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $308.78 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $183.66 | 2019-2022 | |
| Lilly USA, LLC | $132.92 | 2020-2023 | Mounjaro |
| Intuitive Surgical, INC. | $132.49 | 2025 | |
| Novo Nordisk INC | $98.20 | 2019-2024 | Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $41.53 | 2021-2022 | |
| Pfizer INC. | $25.57 | 2023 | |
| Antares Pharma, INC. | $22.82 | 2024 | Xyosted |
| Amgen INC. | $20.12 | 2024 | Otezla, Repatha |
| Abbott Laboratories | $16.01 | 2023 | Freestyle Libre 3 |
| Halozyme INC | $14.53 | 2023 | |
| Dexcom, INC. | $13.30 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $12.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.